β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population

BACKGROUND AND OBJECTIVES: ATN (β-amyloid [Aβ], tau, neurodegeneration) system categorizes individuals based on their core Alzheimer disease (AD) biomarkers. An important potential future use for ATN is therapeutic decision-making in clinical practice once disease-modifying treatments (e.g., anti-am...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Anna, Öhlund-Wistbacka, Ulf, Hall, Anette, Bonnard, Alexandre, Hagman, Göran, Rydén, Marie, Thunborg, Charlotta, Wiggenraad, Fleur, Sandebring-Matton, Anna, Solomon, Alina, Kivipelto, Miia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651451/
https://www.ncbi.nlm.nih.gov/pubmed/36130840
http://dx.doi.org/10.1212/WNL.0000000000201043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651451/
https://www.ncbi.nlm.nih.gov/pubmed/36130840
http://dx.doi.org/10.1212/WNL.0000000000201043

Ejemplares similares